| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |